GNCA vs. GNCAQ, ALVO, VECT, GRTS, NTGN, BLUE, ZIOP, AGEN, AMGN, and GILD
Should you be buying Genocea Biosciences stock or one of its competitors? The main competitors of Genocea Biosciences include Genocea Biosciences (GNCAQ), Alvotech (ALVO), VectivBio (VECT), Gritstone bio (GRTS), Neon Therapeutics (NTGN), bluebird bio (BLUE), ZIOPHARM Oncology (ZIOP), Agenus (AGEN), Amgen (AMGN), and Gilead Sciences (GILD). These companies are all part of the "medical" sector.
Genocea Biosciences (NASDAQ:GNCAQ) and Genocea Biosciences (NASDAQ:GNCA) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, community ranking and risk.
In the previous week, Genocea Biosciences had 1 more articles in the media than Genocea Biosciences. MarketBeat recorded 1 mentions for Genocea Biosciences and 0 mentions for Genocea Biosciences. Genocea Biosciences' average media sentiment score of 0.00 equaled Genocea Biosciences'average media sentiment score.
Genocea Biosciences has a beta of 2.3, suggesting that its stock price is 130% more volatile than the S&P 500. Comparatively, Genocea Biosciences has a beta of 1.61, suggesting that its stock price is 61% more volatile than the S&P 500.
0.6% of Genocea Biosciences shares are owned by institutional investors. 1.6% of Genocea Biosciences shares are owned by insiders. Comparatively, 1.6% of Genocea Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Genocea Biosciences received 388 more outperform votes than Genocea Biosciences when rated by MarketBeat users.
Genocea Biosciences' return on equity of 0.00% beat Genocea Biosciences' return on equity.
Summary
Genocea Biosciences and Genocea Biosciences tied by winning 4 of the 8 factors compared between the two stocks.
Get Genocea Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for GNCA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GNCA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Genocea Biosciences Competitors List
Related Companies and Tools
